The Analysis of Selected miRNAs and Target MDM2 Gene Expression in Oral Squamous Cell Carcinoma

Karolina Gołąbek1, Dorota Hudy1, Jadwiga Gaździcka1

  • 1Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 19 Jordana St., 41-808 Zabrze, Poland.

Biomedicines
|November 25, 2023
PubMed

Insights

This study investigated microRNA-3613-3p (miR-3613-3p) in oral squamous cell carcinoma (OSCC). Overexpression of miR-3613-3p is linked to tumor progression and may serve as a prognostic marker in OSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in cancer development and progression.
  • Murine double minute 2 (MDM2) is an oncoprotein that negatively regulates the tumor suppressor p53.
  • MDM2 targets specific miRNAs, including potential candidates like miR-3613-3p, miR-371b-5p, and miR-3658.

Purpose of the Study:

  • To analyze the expression of MDM2 target miRNAs (miR-3613-3p, miR-371b-5p, miR-3658) and the MDM2 gene in oral squamous cell carcinoma (OSCC) and adjacent margin tissues.
  • To investigate the association of these miRNA and gene expressions with socio-demographic and clinicopathological characteristics in OSCC patients.

Main Methods:

  • Quantitative real-time PCR (qPCR) was used to assess miRNA and MDM2 gene expression levels.
  • The study included 50 OSCC patients, analyzing both tumor and margin samples.

Main Results:

  • Only miR-3613-3p was detected among the targeted miRNAs.
  • No significant difference in miR-3613-3p expression was observed between tumor and margin samples.
  • A statistically significant difference in miR-3613-3p expression was found between smokers and non-smokers.
  • miR-3613-3p expression levels were associated with clinical parameters such as tumor size (T), lymph node involvement (N), and tumor grade (G).

Conclusions:

  • Overexpression of miR-3613-3p is involved in the tumor progression of oral squamous cell carcinoma (OSCC).
  • miR-3613-3p demonstrates potential as a prognostic biomarker for OSCC.